Published in Psychiatr Clin North Am on September 01, 2008
Borderline personality disorder: ontogeny of a diagnosis. Am J Psychiatry (2009) 1.38
Anatomical insights into the interaction of emotion and cognition in the prefrontal cortex. Neurosci Biobehav Rev (2011) 1.31
The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry (2009) 1.28
Structural brain abnormalities and suicidal behavior in borderline personality disorder. J Psychiatr Res (2012) 0.99
Are structural brain abnormalities associated with suicidal behavior in patients with psychotic disorders? J Psychiatr Res (2013) 0.87
ESCAP Expert Article: Borderline personality disorder in adolescence: An expert research review with implications for clinical practice. Eur Child Adolesc Psychiatry (2015) 0.85
Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatr Res (2010) 0.84
A Brief Review of Research Using Near-Infrared Spectroscopy to Measure Activation of the Prefrontal Cortex during Emotional Processing: The Importance of Experimental Design. Front Hum Neurosci (2016) 0.84
Impulsivity, aggression and brain structure in high and low lethality suicide attempters with borderline personality disorder. Psychiatry Res (2014) 0.82
Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder. Behav Brain Res (2010) 0.81
Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences. J Psychiatr Res (2012) 0.80
The association between catastrophizing and craving in patients with chronic pain prescribed opioid therapy: a preliminary analysis. Pain Med (2014) 0.80
Developmental differences in diffusion tensor imaging parameters in borderline personality disorder. J Psychiatr Res (2013) 0.79
Sleep-Wake Patterns of Adolescents with Borderline Personality Disorder and Bipolar Disorder. Child Psychiatry Hum Dev (2016) 0.76
Psychopharmacologic treatment of borderline personality disorder. Dialogues Clin Neurosci (2013) 0.75
Electrocortical Reactivity During Self-referential Processing in Female Youth With Borderline Personality Disorder. Biol Psychiatry Cogn Neurosci Neuroimaging (2016) 0.75
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry (2002) 2.75
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 2.06
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry (2002) 1.81
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 1.71
Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology (2007) 1.54
Abuse and neglect in childhood: relationship to personality disorder diagnoses. CNS Spectr (2003) 1.38
Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res (2007) 1.36
Neural correlates of using distancing to regulate emotional responses to social situations. Neuropsychologia (2010) 1.33
Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder. J Psychiatr Res (2009) 1.32
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale. Personal Disord (2011) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
The interpersonal dimension of borderline personality disorder: toward a neuropeptide model. Am J Psychiatry (2009) 1.28
Personality disorder types proposed for DSM-5. J Pers Disord (2011) 1.27
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry (2002) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry (2005) 1.23
Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry (2005) 1.22
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry (2002) 1.22
Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder. Biol Psychiatry (2009) 1.21
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res (2009) 1.18
The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry (2003) 1.17
Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry (2005) 1.17
Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry (2009) 1.17
The case for shifting borderline personality disorder to Axis I. Biol Psychiatry (2008) 1.14
Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry (2011) 1.12
Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol (2004) 1.12
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder. Biol Psychiatry (2007) 1.11
Cognitive and brain function in schizotypal personality disorder. Schizophr Res (2002) 1.10
Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res (2008) 1.10
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) (2004) 1.07
Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol (2008) 1.07
Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res (2008) 1.07
Potentiated amygdala response to repeated emotional pictures in borderline personality disorder. Biol Psychiatry (2012) 1.06
Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res (2007) 1.05
Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res (2004) 1.05
Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry (2003) 1.04
Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res (2002) 1.04
Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry (2003) 1.03
A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry (2012) 1.02
The role of childhood trauma in differences in affective instability in those with personality disorders. CNS Spectr (2003) 1.00
Complex PTSD is on the trauma spectrum: comment on Resick et al. (2012). J Trauma Stress (2012) 1.00
24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res (2004) 1.00
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res (2010) 0.99
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem (2003) 0.96
Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology (2010) 0.96
The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol Psychiatry (2006) 0.95
Etiological features of borderline personality related characteristics in a birth cohort of 12-year-old children. Dev Psychopathol (2012) 0.95
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage (2008) 0.95
Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res (2009) 0.93
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part II: Clinical application. Personal Disord (2011) 0.92
Neurobiologic function and temperament in subjects with personality disorders. CNS Spectr (2003) 0.92
Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophr Bull (2011) 0.91
Dispositional impulsivity in normal and abnormal samples. J Psychiatr Res (2006) 0.91
Parental burden associated with borderline personality disorder in female offspring. J Pers Disord (2011) 0.91
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry (2010) 0.89
Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology (2010) 0.89
Empathy and alexithymia in borderline personality disorder: clinical and laboratory measures. J Pers Disord (2012) 0.88
Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry (2013) 0.88
Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr Res (2007) 0.88
Low prolactin response to fenfluramine in impulsive aggression. J Psychiatr Res (2004) 0.88
Childhood trauma and basal cortisol in people with personality disorders. Compr Psychiatry (2008) 0.87
Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal personality disorder in a Puerto Rican family. Psychiatr Genet (2005) 0.86
Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia. Neuropsychopharmacology (2012) 0.85
Methodological considerations treatment trials for persons personality disorder. Ann Clin Psychiatry (2010) 0.85
The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572. Am J Med Genet B Neuropsychiatr Genet (2014) 0.85
Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatr Res (2010) 0.84
The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients. Am J Psychiatry (2014) 0.84
Serotonin 2c receptor RNA editing in major depression and suicide. World J Biol Psychiatry (2012) 0.84
The Neurobiological Basis of Adolescent-onset Borderline Personality Disorder. J Can Acad Child Adolesc Psychiatry (2013) 0.84
Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res (2012) 0.84